UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy

Clinical cancer research, 2018-03, Vol.24 (6), p.1315-1325

2018

Volltextzugriff (PDF)

A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3

Clinical cancer research, 2009-01, Vol.15 (1), p.361-367

2009

Volltextzugriff (PDF)

Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer

Cancer research communications, 2023-12, Vol.3 (12), p.2585-2595

2023

Volltextzugriff (PDF)

Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab

Oncoimmunology, 2017-01, Vol.6 (12), p.e1363138-e1363138

2017

Volltextzugriff (PDF)

HLA Class I-Restricted Responses to Vaccinia Recognize a Broad Array of Proteins Mainly Involved in Virulence and Viral Gene Regulation

Proceedings of the National Academy of Sciences - PNAS, 2005-09, Vol.102 (39), p.13980-13985

2005

Volltextzugriff (PDF)

Abstract 5261: Immunologic signatures of peripheral blood cells in patients with advanced pancreatic cancer under lenvatinib-pembrolizumab maintenance therapy

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5261-5261

2024

Volltextzugriff (PDF)

Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells

Cancer Immunology, Immunotherapy, 2016-07, Vol.65 (7), p.869-874

2016

Volltextzugriff (PDF)

Regulation of adaptive immunity by natural killer cells

Immunologic research, 1998-01, Vol.17 (3), p.303-312

Kos, F J

1998

Volltextzugriff (PDF)

Costimulation of T cell receptor-triggered IL-2 production by Jurkat T cells via fibroblast growth factor receptor 1 upon its engagement by CD56

Immunology and cell biology, 2002-08, Vol.80 (4), p.364-369

2002

Volltextzugriff (PDF)

Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium

The Journal of immunology (1950), 2010-12, Vol.185 (11), p.7107-7114

2010

Volltextzugriff (PDF)

A phase 1 study of p53MVA vaccine in combination with pembrolizumab

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.206-206

2018

Volltextzugriff (PDF)

Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide

Oncoimmunology, 2014-01, Vol.3 (1), p.e27357-e27357

2014

Volltextzugriff (PDF)

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

Cancer Immunology, Immunotherapy, 2008-03, Vol.57 (3), p.303-315

2008

Volltextzugriff (PDF)

Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells

Blood, 2011-01, Vol.117 (2), p.608-617

2011

Volltextzugriff (PDF)

Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity

The Journal of immunology (1950), 2013-11, Vol.191 (10), p.5097-5106

2013

Volltextzugriff (PDF)

Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3

Cancer Immunology, Immunotherapy, 2010-05, Vol.59 (5), p.799-803

2010

Volltextzugriff (PDF)

Structure-based design of altered MHC II-restricted peptide ligands with heterogeneous immunogenicity1

The Journal of immunology (1950), 2013-10, Vol.191 (10)

2013

Volltextzugriff (PDF)

Favorable Immune Reconstitution After Nonmyeloablative, T-Cell Replete, HLA-Haploidentical BMT with Post-Transplant Cyclophosphamide

Blood, 2011-11, Vol.118 (21), p.1009-1009

2011

Volltextzugriff (PDF)

Immune Recovery after Timed Sequential Therapy in Acute Myelogenous Leukemia: Discordant Recovery of Naïve T Lymphocytes and Antigen Driven Regulatory T Cells

Blood, 2008-11, Vol.112 (11), p.947-947

2008

Volltextzugriff (PDF)

Immune Recovery after Timed Sequential Therapy in Acute Myelogenous Leukemia: Discordant Recovery of Naïve T Lymphocytes and Antigen Driven Regulatory T Cells

Blood, 2008-11, Vol.112 (11), p.947-947

2008

Volltextzugriff (PDF)

Cervical mucosal CD8 T cells are more predictive of HPV lesion regression than systemic HPV-specific response (48.13)

The Journal of immunology (1950), 2010-04, Vol.184 (1_Supplement), p.48-48.13

2010

Volltextzugriff (PDF)

Characterization of Immune Reconstitution Following High Dose Chemotherapy in Acute Myeloid Leukemia

Blood, 2007-11, Vol.110 (11), p.3888-3888

2007

Volltextzugriff (PDF)

Antigen-specific recognition by class I major histocompatibility complex restricted T cells and activation of CD8+ memory cytotoxic T cells

Canadian journal of microbiology, 1993-02, Vol.39 (2), p.141-157

Kos, F J

1993

Volltextzugriff (PDF)

Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes

The Journal of experimental medicine, 1994-12, Vol.180 (6), p.2209-2218

1994

Volltextzugriff (PDF)

Su.98. Mechanisms of Immune Privilege in High Grade Cervical Dysplasia

Clinical immunology (Orlando, Fla.), 2008, Vol.127, p.S156-S156

2008

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(33)
Berichte
(1)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(20)
Immunology
(18)
Humans
(15)
Female
(10)
Animals
(9)
T-Lymphocytes, Cytotoxic - Immunology
(9)
Biological And Medical Sciences
(8)
Oncology
(8)
Immunotherapy
(6)
Mice
(6)
T-Lymphocytes - Immunology
(5)
Vaccinia
(5)
Antigens, Viral - Immunology
(4)
Cd8-Positive T-Lymphocytes - Immunology
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Fundamental Immunology
(4)
Immunobiology
(4)
Medical Sciences
(4)
Mice, Inbred Balb C
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy

A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3

Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer

Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab

HLA Class I-Restricted Responses to Vaccinia Recognize a Broad Array of Proteins Mainly Involved in Virulence and Viral Gene Regulation

Abstract 5261: Immunologic signatures of peripheral blood cells in patients with advanced pancreatic cancer under lenvatinib-pembrolizumab maintenance therapy

Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells

Regulation of adaptive immunity by natural killer cells

Costimulation of T cell receptor-triggered IL-2 production by Jurkat T cells via fibroblast growth factor receptor 1 upon its engagement by CD56

Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium

A phase 1 study of p53MVA vaccine in combination with pembrolizumab

Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells

Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity

Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3

Structure-based design of altered MHC II-restricted peptide ligands with heterogeneous immunogenicity1

Favorable Immune Reconstitution After Nonmyeloablative, T-Cell Replete, HLA-Haploidentical BMT with Post-Transplant Cyclophosphamide

Immune Recovery after Timed Sequential Therapy in Acute Myelogenous Leukemia: Discordant Recovery of Naïve T Lymphocytes and Antigen Driven Regulatory T Cells

Immune Recovery after Timed Sequential Therapy in Acute Myelogenous Leukemia: Discordant Recovery of Naïve T Lymphocytes and Antigen Driven Regulatory T Cells

Cervical mucosal CD8 T cells are more predictive of HPV lesion regression than systemic HPV-specific response (48.13)

Characterization of Immune Reconstitution Following High Dose Chemotherapy in Acute Myeloid Leukemia

Antigen-specific recognition by class I major histocompatibility complex restricted T cells and activation of CD8+ memory cytotoxic T cells

Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes

Su.98. Mechanisms of Immune Privilege in High Grade Cervical Dysplasia

Suchergebnisse filtern